Apogee Therapeutics Inc (APGE) PT Lowered to $116 at Deutsche Bank
Tweet
Share
E-mailGet Alerts APGE Hot Sheet
Price: $134.26 +0.13%
Rating Summary:
6 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 0
Rating Summary:
6 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 0
Join SI Premium – FREE
Deutsche Bank analyst David Hoang lowered the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $116.00 (from $118.00) while maintaining a Buy rating.
You May Also Be Interested In
- Pollen Street Group (POLN:LN) PT Raised to GBP13.20 at Berenberg
- Cantor Fitzgerald Downgrades DOMO (DOMO) to Neutral
- Auction Technology Group (ATG:LN) PT Raised to GBP4.90 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
